TNFA (tnfpharma.com) Net Profit

TNF Pharmaceuticals generates revenue from licensing unique anti-inflammatory formulas, with business success driven by the outcomes of clinical trials for targeted drugs. This GURU.Markets terminal chart displays the company's profit, where the indicator value is -0.01. Strategic partnerships with biotech laboratories specializing in inflammation create synergy, significantly enhancing the issuer's investment attractiveness for M&A transactions.

TNFA (tnfpharma.com) Company Net Income history from 07/25/2024 to 09/25/2025

Financial and market metric breakdowns for tnfpharma.com (TNFA)

- price and consensus price forecast:
Stock Quotes TNF Pharmaceuticals, Inc.|TNFA - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization TNF Pharmaceuticals, Inc.|TNFA - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share TNF Pharmaceuticals|TNFA - Company Book Value|Market-to-Book Ratio tnfpharma.com|TNFA - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital TNF Pharmaceuticals|TNFA - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital TNF Pharmaceuticals, Inc.|TNFA - Company Aggregate Debts|Debts to Book Value TNF Pharmaceuticals, Inc.|TNFA - Company Long-Term Debt|Company Short-Term Loans and Borrowings TNF Pharmaceuticals|Intermediate Liquidity Ratio tnfpharma.com
- net income and valuation multiples indicators:
TNFA - Company Net Income
Fundamental valuation:TNFA TNF Pharma

This indicator reflects daily net profit dynamics, allowing investors to track real-time business efficiency without quarterly lags. For TNF Pharmaceuticals (TNFA), the company's book profit demonstrates how the implementation of eco-friendly closed-loop production and ESG standards impacts financial stability, transforming technological modernization into a long-term driver of asset value growth.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Theravance Biopharma, Inc. - Net Income|Profit After Payment of Taxes AQST (Aquestive Therapeutics Inc)|SCPH - Company Net Income|TECX (Tectonic Therapeutic, Inc.) - Company Profit|TNXP: Net Profit|Profit After Tax SXTC (China SXT Pharmaceuticals, Inc.)|Net Income EPRX|BHST: Final Profit|Company Net Income Invizyne Technologies, Inc. (EXOZ)|ORMP: Profit After Tax|Net Profit ENTX (Entera Bio)|Final Profit HYFT|ABVC BioPharma, Inc. - Net Profit|CPIX - Net Profit|Quantum BioPharma Limited (QNTM) - Company Net Income|FibroGen Corporation - Final Profit|Company Net Income Telomir Pharmaceuticals|Net Income Rani Therapeutics Inc (RANI)|Net Profit SNYR|Net Profit rallybio.com (RLYB)|Net Profit LEXX (Lexaria Bioscience Corp.)|PULM - Net Income|Pheton - Net Profit|Company Net Income Aptorum Group Limited|LYRA (Lyra Therapeutics) - Net Income|impactbiomedinc.com (IBO) - Net Profit|Net Income YCBD|PRFX (PainReform Corp) - Profit After Payment of Taxes|Net Profit CYTO|Net Financial Result lipella.com|Net Profit OPTN (OptiNose)|PIRS - Net Income|Procaps Group SA - Net Profit|PTPI - Net Profit|Qilian International (QLI) - Company Net Income|SLRN (acelyrin.com) - Company Net Income|Company Net Income TFF Pharmaceuticals, Inc.